These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 30514664)

  • 1. Regulatory and effector B cells: Friends or foes?
    Matsushita T
    J Dermatol Sci; 2019 Jan; 93(1):2-7. PubMed ID: 30514664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance.
    Matsushita T; Kobayashi T; Mizumaki K; Kano M; Sawada T; Tennichi M; Okamura A; Hamaguchi Y; Iwakura Y; Hasegawa M; Fujimoto M; Takehara K
    Sci Adv; 2018 Jul; 4(7):eaas9944. PubMed ID: 30009261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory B cells and T cell Regulation in Cancer.
    Horii M; Matsushita T
    J Mol Biol; 2021 Jan; 433(1):166685. PubMed ID: 33096106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Proinflammatory Cytokine Network Profile in Th1/Type 1 Effector B Cells Delineates a Common Group of Patients in Four Systemic Autoimmune Diseases.
    Simon Q; Grasseau A; Boudigou M; Le Pottier L; Bettachioli E; Cornec D; Rouvière B; Jamin C; Le Lann L; ; ; Borghi MO; Aguilar-Quesada R; Renaudineau Y; Alarcón-Riquelme ME; Pers JO; Hillion S
    Arthritis Rheumatol; 2021 Aug; 73(8):1550-1561. PubMed ID: 33605069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory B cells in human inflammatory and autoimmune diseases: from mouse models to clinical research.
    Miyagaki T; Fujimoto M; Sato S
    Int Immunol; 2015 Oct; 27(10):495-504. PubMed ID: 25957264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effector and regulatory B-cell imbalance in systemic sclerosis: cooperation or competition?
    Liu M
    Clin Rheumatol; 2024 Sep; 43(9):2783-2789. PubMed ID: 39080112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research Progress on Regulatory B Cells in Systemic Lupus Erythematosus.
    Wang T; Mei Y; Li Z
    Biomed Res Int; 2019; 2019():7948687. PubMed ID: 31240224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIM-1 defines a human regulatory B cell population that is altered in frequency and function in systemic sclerosis patients.
    Aravena O; Ferrier A; Menon M; Mauri C; Aguillón JC; Soto L; Catalán D
    Arthritis Res Ther; 2017 Jan; 19(1):8. PubMed ID: 28103916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances of Regulatory B Cells in Autoimmune Diseases.
    Zhu Q; Rui K; Wang S; Tian J
    Front Immunol; 2021; 12():592914. PubMed ID: 33936028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regulatory B cells in human autoimmune diseases].
    Miyagaki T
    Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(5):390-7. PubMed ID: 26725860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired suppressive capacity of activation-induced regulatory B cells in systemic lupus erythematosus.
    Gao N; Dresel J; Eckstein V; Gellert R; Störch H; Venigalla RK; Schwenger V; Max R; Blank N; Lorenz HM; Tretter T
    Arthritis Rheumatol; 2014 Oct; 66(10):2849-61. PubMed ID: 24942956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of intracellular cytokines and regulatory cells in patients with autoimmune diseases and primary immunodeficiencies - novel tool for diagnostics and patient follow-up.
    Osnes LT; Nakken B; Bodolay E; Szodoray P
    Autoimmun Rev; 2013 Aug; 12(10):967-71. PubMed ID: 23541481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 35 Regulatory B Cells.
    Choi JK; Egwuagu CE
    J Mol Biol; 2021 Jan; 433(1):166607. PubMed ID: 32755620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid-Derived Suppressor Cells Induce the Expansion of Regulatory B Cells and Ameliorate Autoimmunity in the Sanroque Mouse Model of Systemic Lupus Erythematosus.
    Park MJ; Lee SH; Kim EK; Lee EJ; Park SH; Kwok SK; Cho ML
    Arthritis Rheumatol; 2016 Nov; 68(11):2717-2727. PubMed ID: 27214349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Unknown Aspect of BAFF: Inducing IL-35 Production by a CD5
    Zhang Y; Li J; Zhou N; Zhang Y; Wu M; Xu J; Shen C; An X; Shen G; Yang M; Zhang C; Tao J
    J Invest Dermatol; 2017 Dec; 137(12):2532-2543. PubMed ID: 28844943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effector and regulatory B cells in immune-mediated kidney disease.
    Oleinika K; Mauri C; Salama AD
    Nat Rev Nephrol; 2019 Jan; 15(1):11-26. PubMed ID: 30443016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-9 and T helper type 9 cells in rheumatic diseases.
    Ciccia F; Guggino G; Ferrante A; Cipriani P; Giacomelli R; Triolo G
    Clin Exp Immunol; 2016 Aug; 185(2):125-32. PubMed ID: 27159882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune regulatory function of B cells.
    Mauri C; Bosma A
    Annu Rev Immunol; 2012; 30():221-41. PubMed ID: 22224776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cells present skewed profile and lose the function of supporting T cell inflammation after Roux-en-Y gastric bypass.
    Dai X; Zhao W; Zhan J; Zeng S; Ran D; Zhang H; Song Z; Song KH; Wu L
    Int Immunopharmacol; 2017 Feb; 43():16-22. PubMed ID: 27936460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin-Associated B Cells in the Pathogenesis of Cutaneous Autoimmune Diseases-Implications for Therapeutic Approaches.
    Fetter T; Niebel D; Braegelmann C; Wenzel J
    Cells; 2020 Dec; 9(12):. PubMed ID: 33297481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.